The suit from 19 states and the District of Columbia contends that major restructuring has cut life-saving programs and put extra burden on states to pay for health crises.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
One study finds that staff working at more than one nursing home had quadruple the risk of infection.
An observational study of 10,021 COVID-19 patients admitted to 920 German hospitals has found that patients requiring mechanical ventilation were at highest risk for death—especially those 80 years and older and those needing dialysis.
Some CDC data assessment may perpetuate racial disparities, one study finds.
Arizona has seen a 13% decrease in its 7-day average, Florida an 8% drop, and Texas a 19% decline.
Vietnam, Greece, Germany, and other nations that had low levels scramble to address flare-ups.
More than 2 million American workers called in sick in a single week in mid-April, causing the highest absence rate on record and leading to suspicions that COVID-19 cases were substantially undercounted, according to a research letter published yesterday in JAMA Internal Medicine.
WHO officials stressed that even intense transmission countries can turn their outbreaks around with leadership, consistent messaging, and key measures.
The vaccine trial is starting against a backdrop of a vigorous US outbreak, in which three states outside the main hot spots reported record highs: Oklahoma, Missouri, and North Dakota.
Two German studies published today in JAMA Cardiology show abnormal heart imaging findings in recently recovered COVID-19 patients.
In a comparative analysis published late last week in Clinical Infectious Diseases, the antiviral drug remdesivir was linked to significantly greater recovery and a 62% lower death rate by day 14 versus standard treatment in hospitalized adults with severe COVID-19.
